NRx Defense Systems, Inc.
North Bay Village, Florida, United StatesSee on the map
- Neuromodulation
- Depression
NRx Defense Systems is a clinical technology company developing neuroscience-based treatments for PTSD, depression, and suicidality among military personnel, veterans, first responders, and other service populations. Its platform combines MRI neuronavigation, robotic transcranial magnetic stimulation (TMS), and investigational neuroplastic medication, with an $11 million DARPA prime contract supporting its evaluation.
- Open roles
- 3
- RaisedTotal raised
- $40.7M
reccy insights
NRx Defense Systems has advanced its clinical and defense-focused neuroscience pipeline through significant capital raises and high-profile research collaborations. On April 17, 2025, the company secured $20,000,000 through an ATM offering, followed by an additional $20,716,000 via an underwritten public offering on June 4, 2026, bringing its total tracked funding to nearly $33 million. The company is actively developing advanced treatments for treatment-resistant PTSD, depression, and suicidality among military personnel, veterans, and first responders. A cornerstone of its recent momentum is an $11 million prime contract from DARPA, which supports the evaluation of robotically controlled transcranial magnetic stimulation (TMS) combined with the investigational neuroplastic medication NRX-101. Furthermore, NRx Defense Systems has established strategic clinical and research partnerships with institutions such as Harvard McLean Hospital and HOPE Therapeutics to accelerate the deployment of its precision neuromodulation protocols.
Written by reccy's AI from company sites, press and funding records · updated Nov 2026
Open roles3
- Added to reccy 1d ago
Military & Veteran Outreach Coordinator
Remote · Mid · Added to reccy 1d ago
- Added to reccy 1d ago
Federal Contracts & Compliance Manager
Remote · Manager · Added to reccy 1d ago
- Added to reccy 1d ago
Clinical Research Coordinator
Sarasota & West Palm Beach, FL · Mid · Added to reccy 1d ago
What makes NRx Defense Systems, Inc. distinct
- 01Combines MRI neuronavigation, robotic TMS, and investigational neuroplastic medication in a precision treatment protocol.
- 02Focuses on treatment-resistant PTSD and depression in military and other service populations.
- 03Holds an $11 million DARPA prime contract to evaluate robotic magnetic stimulation with NRX-101.
- 04Works with Harvard McLean Hospital and HOPE Therapeutics on research and clinical deployment.
- 05Brings together clinicians, neuroscience researchers, engineers, veterans, and defense-sector leaders.
Technology & products
- NRX-101 Protocol
An investigational neuroplastic medication combined with MRI neuronavigation and robotic TMS for treatment-resistant PTSD and depression.
- MRI neuronavigation
- Robotically controlled transcranial magnetic stimulation (TMS)
- Integrated TMS and neuroplastic medication protocol
- NRX-101, an investigational neuroplastic medication
Funding
- Underwritten Public OfferingJun 2026$20.7M
- ATM OfferingApr 2025$20M
Similar companies
About NRx Defense Systems, Inc.
- Products
- NRX-101 Protocol
- Focus areas
- Mental health, neuromodulation, tms, military health, ptsd, depression, clinical research, defense technology
- Headquarters
- North Bay Village, Florida, United States